Ep. 131: “Lymphocyte Development” Featuring Dr. Alfred Singer

The Immunology Podcast1h 10mMay 5, 2026

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Ep. 131: “Lymphocyte Development” Featuring Dr. Alfred Singer” inside PodZeus.

AI-Generated Summary

In this episode of The Immunology Podcast, hosts Dr. Jason Goldsmith and Dr. Brenda Radd welcome Dr. Alfred Singer from the National Cancer Institute Center for Cancer Research to discuss the intricate process of lymphocyte development, particularly focusing on T-cell differentiation in the thymus. The conversation traces the evolution of understanding T-cell receptor signaling, coreceptor selection, and the kinetic signaling model that determines whether a double-positive thymocyte becomes a CD4 helper or CD8 cytotoxic T cell. Dr. Singer shares pivotal insights from his lab, including the discovery that TCR signaling disrupts CD8 expression, and that the persistence or disruption of this signal dictates lineage fate—via cytokine responsiveness and transcription factor activation. The episode also covers recent immunology research highlights, including mRNA vaccine mechanisms involving dendritic cell cross-dressing, Treg ablation triggering NK cell-mediated tumor control, and a human immune aging clock identifying RunX1 as a key regulator of T-cell senescence. The hosts emphasize the complexity and plasticity of immune cell fate, challenging the notion of rigid lineage boundaries.

Key Takeaways
1

T-cell lineage fate is determined by the duration and disruption of TCR signaling, not by intrinsic properties of CD4 or CD8 proteins.

2

Dendritic cells can acquire antigen from non-hematopoietic cells via trogocytosis (cross-dressing), enabling systemic T-cell priming after mRNA vaccination.

3

Depleting intratumoral Tregs activates a CD4–DC2–IL-2–NK cell axis that controls MHC-I-deficient tumors.

4

RunX1 acts as a decelerator of T-cell senescence; its decline with age contributes to loss of T-cell diversity and function.

5

The 'kinetic signaling model' explains how double-positive thymocytes interpret TCR signals to choose CD4 or CD8 fate through CD8 downregulation and signal persistence.

Chapters
0:00
7 min

Introduction and Sponsorship: Stem Cell Technologies

The hosts introduce the episode, welcome Dr. Alfred Singer, and promote Stem Cell Technologies' PBMC isolation kits and free sample offers.

6:40
10 min

Immunology News Roundup: Bat Coronaviruses and mRNA Vaccines

There's something about the LNP mRNA format that activates interferon type 1 signaling, which seems to be dependent on this cross-dressing ability.

Highlight
16:40
17 min

Tumor Immune Evasion and NK Cell Activation

When you pull out the Tregs, the DC2s activate CD4 cells, which pump out IL-2, which tones the NK cells on.

Highlight
33:20
17 min

Immune Aging and RunX1 as a Senescence Decelerator

RunX1 works as a repressor of these phenotypes. If they overexpress RunX1, they can reverse some of the senescent-associated transcriptome.

Highlight
50:00
65 min

Deep Dive: T-Cell Development with Dr. Alfred Singer

Dr. Singer explains the kinetic signaling model of T-cell lineage commitment, the role of CD8 downregulation, and how signal persistence determines CD4 vs CD8 fate. He discusses the evolution of the field, including the shift from co-receptor-centric to signaling-duration models.

High-Impact Quotes
Hard work is no substitute for hard thinking.
Dr. Alfred Singer67:27
Viral: 90.0
The only way that T cell receptors that signal can signal is if they somehow get access to the LCK proteins, the enzymes that are attached to the co-receptors.
Dr. Alfred Singer51:00
Viral: 85.0
Life is supposed to be fun. This is all fun. This is really fun.
Dr. Alfred Singer67:11
Viral: 85.0
Speakers

Hosts

Dr. Jason GoldsmithDr. Brenda Radd

Guest

Dr. Alfred Singer
Topics Discussed
T-cell development95%Thymic selection90%Kinetic signaling model90%Dendritic cell cross-dressing85%T-cell senescence80%mRNA vaccine mechanisms75%Tumor immune evasion70%Immune aging70%
People & Brands

Dr. Alfred Singer

person

12xPositive

CD8

other

12xNeutral

CD4

other

10xNeutral

NK cells

other

7xPositive

DC2s

other

6xPositive

IL-2

other

5xPositive

Stem Cell Technologies

organization

5xPositive

RunX1

other

5xPositive

National Cancer Institute Center for Cancer Research

organization

4xPositive

mRNA LNP vaccination

other

4xPositive

Get the full intelligence

Search transcripts, export clips, track mentions, and explore all topics from “Ep. 131: “Lymphocyte Development” Featuring Dr. Alfred Singer” inside PodZeus.

Start discovering podcast insights today

Start with a 7-day trial and explore a growing catalog of popular podcasts. No credit card required.

No credit card required • 7-day trial • Cancel anytime